Novonix (NVX) Equity Average (2021 - 2025)
Novonix's Equity Average history spans 5 years, with the latest figure at $149.6 million for Q4 2025.
- For Q4 2025, Equity Average fell 6.92% year-over-year to $149.6 million; the TTM value through Dec 2025 reached $149.6 million, down 6.92%, while the annual FY2025 figure was $149.6 million, 6.92% down from the prior year.
- Equity Average reached $149.6 million in Q4 2025 per NVX's latest filing, down from $160.8 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $243.5 million in Q4 2022 to a low of $93.3 million in Q2 2021.
- Average Equity Average over 5 years is $175.6 million, with a median of $181.1 million recorded in 2022.
- Peak YoY movement for Equity Average: surged 116.04% in 2022, then dropped 21.58% in 2024.
- A 5-year view of Equity Average shows it stood at $93.3 million in 2021, then soared by 161.11% to $243.5 million in 2022, then decreased by 15.82% to $205.0 million in 2023, then decreased by 21.58% to $160.8 million in 2024, then dropped by 6.92% to $149.6 million in 2025.
- Per Business Quant, the three most recent readings for NVX's Equity Average are $149.6 million (Q4 2025), $160.8 million (Q4 2024), and $205.0 million (Q4 2023).